Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.
Open Access
- 1 April 1982
- journal article
- Published by Wiley
- Vol. 14 (S2), 97S-101S
- https://doi.org/10.1111/j.1365-2125.1982.tb02064.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Safety and Efficacy of Chronic Therapy with Captopril in Hypertensive Patients: An UpdateThe Journal of Clinical Pharmacology, 1981
- Racial differences in pressure, volume and renin interrelationships in essential hypertension.Hypertension, 1979
- Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agentProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranololThe American Journal of Medicine, 1976